Literature DB >> 572655

Effects of ribavirin on BHK-21 cells acutely or persistently infected with mumps virus.

J R McCammon, V W Riesser.   

Abstract

The effects of ribavirin on BHK-21 cells acutely infected with mumps virus were compared to the effects of the drug on the same cell line persistently infected with mumps virus. Visible cytotoxicity was minimal for both cell types; however, there was an inhibition of cell replication with increasing drug concentrations. Ribavirin had marked antiviral activity against both the acute and persistent infections as determined by an inhibition of hemadsorption plaque formation, decreased immunofluorescence, and a reduction in the release of infectious virus. Even after the drug had been on the persistently infected cells for 72 h, there was still antigen production detectable by immunofluorescence, although the cells no longer hemadsorbed chicken erythrocytes. Ribavirin removal from both types of infection resulted in the renewed synthesis of virus.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 572655      PMCID: PMC352665          DOI: 10.1128/AAC.15.3.356

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  10 in total

1.  Antiviral, immunosuppressive and antitumour effects of ribavirin.

Authors:  C W Potter; J P Phair; L Vodinelich; R Fenton; R Jennings
Journal:  Nature       Date:  1976-02-12       Impact factor: 49.962

2.  Efficacy of 1-beta-D-ribofuranosyl-1,2,4-triazole-3-carboxamide against influenza virus infections in mice.

Authors:  F E Durr; H F Lindh; M Forbes
Journal:  Antimicrob Agents Chemother       Date:  1975-05       Impact factor: 5.191

3.  In vitro antiviral efficacy of ribavirin against feline calicivirus, feline viral rhinotracheitis virus, and canine parainfluenza virus.

Authors:  R C Povey
Journal:  Am J Vet Res       Date:  1978-01       Impact factor: 1.156

4.  Design, synthesis, and broad spectrum antiviral activity of 1- -D-ribofuranosyl-1,2,4-triazole-3-carboxamide and related nucleosides.

Authors:  J T Witkowski; R K Robins; R W Sidwell; L N Simon
Journal:  J Med Chem       Date:  1972-11       Impact factor: 7.446

5.  An immuno-cytopathogenic interaction between sensitized leukocytes and epithelial cells carrying a persistent noncytocidal myxovirus infection.

Authors:  L F Speel; J E Osborn; D L Walker
Journal:  J Immunol       Date:  1968-09       Impact factor: 5.422

6.  Double-blind evaluation of oral ribavirin (Virazole) in experimental influenza A virus infection in volunteers.

Authors:  C R Magnussen; R G Douglas; R F Betts; F K Roth; M P Meagher
Journal:  Antimicrob Agents Chemother       Date:  1977-10       Impact factor: 5.191

7.  Broad-spectrum antiviral activity of Virazole: 1-beta-D-ribofuranosyl-1,2,4-triazole-3-carboxamide.

Authors:  R W Sidwell; J H Huffman; G P Khare; L B Allen; J T Witkowski; R K Robins
Journal:  Science       Date:  1972-08-25       Impact factor: 47.728

8.  Mechanism of action of 1- -D-ribofuranosyl-1,2,4-triazole-3-carboxamide (Virazole), a new broad-spectrum antiviral agent.

Authors:  D G Streeter; J T Witkowski; G P Khare; R W Sidwell; R J Bauer; R K Robins; L N Simon
Journal:  Proc Natl Acad Sci U S A       Date:  1973-04       Impact factor: 11.205

9.  Ribavirin: efficacy in the treatment of murine autoimmune disease.

Authors:  L W Klassen; D R Budman; G W Williams; A D Steinberg; N L Gerber
Journal:  Science       Date:  1977-02-25       Impact factor: 47.728

10.  In vitro effect of 1-beta-D-ribofuranosyl-1,2,4-triazole-3-carboxamide (virazole, ICN 1229) on deoxyribonucleic acid and ribonucleic acid viruses.

Authors:  J H Huffman; R W Sidwell; G P Khare; J T Witkowski; L B Allen; R K Robins
Journal:  Antimicrob Agents Chemother       Date:  1973-02       Impact factor: 5.191

  10 in total
  8 in total

1.  Ribavirin cures cells of a persistent infection with foot-and-mouth disease virus in vitro.

Authors:  J C de la Torre; B Alarcón; E Martínez-Salas; L Carrasco; E Domingo
Journal:  J Virol       Date:  1987-01       Impact factor: 5.103

2.  Effect of ribavirin on hepatitis A virus replication in vitro.

Authors:  R K Chaudhary; A P Andonov
Journal:  Can J Infect Dis       Date:  1992-03

3.  Broad-spectrum antiviral activity of 2-beta-D-ribofuranosylselenazole-4-carboxamide, a new antiviral agent.

Authors:  J J Kirsi; J A North; P A McKernan; B K Murray; P G Canonico; J W Huggins; P C Srivastava; R K Robins
Journal:  Antimicrob Agents Chemother       Date:  1983-09       Impact factor: 5.191

4.  A model virus-cell system to study the persistence of African swine fever virus.

Authors:  C Gil-Fernández; D García-Villalón
Journal:  Arch Virol       Date:  1988       Impact factor: 2.574

5.  In vitro antiviral efficacy of pleconaril and ribavirin on foot-and-mouth disease virus replication.

Authors:  Sarkar Soumajit; Ramasamy Periyasamy Tamil Selvan; Veerakyathappa Bhanuprakash
Journal:  Virusdisease       Date:  2019-12-05

6.  Virus susceptibility of Chinese hamster ovary (CHO) cells and detection of viral contaminations by adventitious agent testing.

Authors:  Andreas Berting; Maria R Farcet; Thomas R Kreil
Journal:  Biotechnol Bioeng       Date:  2010-07-01       Impact factor: 4.530

7.  Influence of Ribavirin on Mumps Virus Population Diversity.

Authors:  Mirna Jurković; Anamarija Slović; Dubravko Forčić; Jelena Ivančić-Jelečki; Tanja Košutić-Gulija; Maja Jagušić
Journal:  Viruses       Date:  2021-12-17       Impact factor: 5.048

8.  Characterization of synthetic Chikungunya viruses based on the consensus sequence of recent E1-226V isolates.

Authors:  Florine E M Scholte; Ali Tas; Byron E E Martina; Paolo Cordioli; Krishna Narayanan; Shinji Makino; Eric J Snijder; Martijn J van Hemert
Journal:  PLoS One       Date:  2013-08-01       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.